Analysts Ratings
|
| Current Rating: |  Strong Buy (1.19) |
| Previous Rating: | Strong Buy (1.20) |
| Average Target Price: | $2,107.50 |
| Current Industry Rating: | Buy (1.70) |
| Previous Industry Rating: | Buy (1.82) |
|
|
1=Strong Buy |
5=Strong Sell |
|
|
|
| Date |
Firm |
Action |
Rating |
Previous |
Target |
Previous |
| 1/9/2019 |
Bank of America-Merrill Lynch |
Set Target Price
|
Intermed. Term Neutral |
|
$2,100.00 |
N/A |
| 1/7/2019 |
Pivotal Research Group |
Established Rating
|
Buy |
Buy |
$1,920.00 |
N/A |
| 10/30/2018 |
Aegis Capital |
Raised Target Price
|
Buy |
|
$2,225.00 |
$2,063.00 |
| 10/29/2018 |
JMP Securities LLC |
Lowered Target Price
|
Mkt Perform |
|
$2,050.00 |
$2,075.00 |
| 10/26/2018 |
Barclays Capital |
Lowered Target Price
|
Neutral |
|
$1,950.00 |
$2,100.00 |
| 10/22/2018 |
Credit Suisse |
Raised Target Price
|
Hold |
|
$2,400.00 |
$2,100.00 |
|
|
|
|
|
